Biotricity Inc. (BTCY)
0.33
-0.02 (-5.71%)
At close: Jan 21, 2025, 3:55 PM
0.43
32.62%
After-hours Aug 02, 2024, 07:58 PM EDT
undefined% (undefined)
| Bid | 0.43 |
| Market Cap | 7.93M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -1.28 |
| PE Ratio (ttm) | -0.25 |
| Forward PE | n/a |
| Analyst | Hold |
| Ask | 0.44 |
| Volume | 14,817 |
| Avg. Volume (20D) | 73,287 |
| Open | 0.35 |
| Previous Close | 0.35 |
| Day's Range | 0.31 - 0.35 |
| 52-Week Range | 0.19 - 1.67 |
| Beta | undefined |
About BTCY
Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions primarily in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synth...
Industry Medical - Devices
Sector Healthcare
IPO Date Feb 16, 2018
Employees 55
Stock Exchange NASDAQ
Ticker Symbol BTCY
Website https://www.biotricity.com
Analyst Forecast
According to 1 analyst ratings, the average rating for BTCY stock is "Hold." The 12-month stock price forecast is $undefined, which is a decrease of NaN% from the latest price.
Buy 0.00%
Hold 100.00%
Sell 0.00%
6 months ago
+16.01%
Biotricity shares are trading higher after the com...
Unlock content with
Pro Subscription
